|
|
 |
|
| Description |
| CD45 MicroBeads are used for the depletion or enrichment of leukocytes from peripheral blood, lymphoid tissue, tumor tissue, or non-hematopoietic tissue. CD45 is expressed on all cells of hematopoietic origin except erythrocytes and platelets and their precursor cells. |
| Applications |
| CD45 MicroBeads have been used to enrich non-hematopoietic tumor cells from peripheral blood, bone marrow, or lymph nodes of patients by depletion of CD45+ leukocytes.1–4 |
| |
| Figure 1 |
| A cytokeratin-positive cell was enriched from bone marrow of a patient with renal carcinoma by depletion of leukocytes using CD45 MicroBeads. Cells were stained using a conventional APAAP method followed by staining with hematoxylin. (Courtesy of Dr. Bilkenroth, Dept. Pathol. and Dr. Meye, Dept. Urol., Univ. Halle, Germany.) |
 |
|
| Figure 2 |
| Enrichment of tumor cells from a mixture of PBMCs and cells of the breast cancer cell line SK-BR3 using CD45 MicroBeads. |
| A: Cell mixture before separation (7×106 PBMCs were spiked with 20,000 tumor cells) |
 |
| B: Negative fraction with enriched breast cancer cells |
 |
|
|
|
|
| Favorites / Prices |
Request prices or add products to your favorite list.
|
| Details |
|
| Products |
| CD45 MicroBeads, human |
| For research use only |
- for 109 total cells
Download datasheet
130-045-801
|
|
| References |
| 1. Iinuma et al. (2000) Int. J. Cancer (Ped. Oncol.) 89: 337–344. |
| 2. Bilkenroth et al. (2001) Int. J Cancer 92: 577–582. |
| 3. Meye et al. (2002) Int. J. Oncol. 21: 521–530. |
| 4. Ellis et al. (2003) Urology 61: 277–281. |
|
|
|
© 1999 - 2012 Miltenyi Biotec ¦ Terms & conditions ¦ Legal notes
|
